M. Mukherjee (Hamilton (ON), Canada), K. Jahn (Basel, Switzerland)
Azurocidin-1: a marker of COPD severity and microbial dysbiosis
J. Pollock (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), M. Lonergan (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), A. Smith (Dundee, United Kingdom), M. Crichton (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), B. Miller (Collegeville, PA, United States of America), R. Tal-Singer (Collegeville, PA, United States of America), J. Chalmers (Dundee, United Kingdom)
|   |
Neutrophil extracellular traps levels are associated to severity and complications in community-acquired pneumonia
P. Gonzalez Jimenez (Valencia, Spain), R. Méndez (Valencia, Spain), L. Feced (Valencia, Spain), M. Fernández-Pérez (Murcia, Spain), R. González-Conejero (Murcia, Spain), C. Martínez (Murcia, Spain), A. Latorre (Valencia, Spain), A. Moscardó (Valencia, Spain), R. Menéndez (Valencia, Spain)
| |
Protein profile of COPD patients with Pseudomonas in their airway secretions
S. Pascual-Guardia (Barcelona, Spain), R. Mas (Barcelona, Spain), R. Faner (Barcelona, Spain), A. Castro-Acosta (Madrid, Spain), G. Peces-Barba (BMadrid, Spain), B. Cosio (Palma, Spain), A. Agustí (Barcelona, Spain), E. Monsó (Sabadell, Spain), J. Gea Guiral (Barcelona, Spain)
| |
Vitamin D as a marker of worsening of the course of pneumonia.
T. Luchnikova (Blagoveshchensk (Amur Oblast), Russian Federation), O. Prikhodko (Blagoveshchensk (Amur Oblast), Russian Federation)
| |
Composition ration and drug-sensitivity distribution of phlegmy patogenic bacteria from AECOPD inpatients
T. Ma (Changchun, China), Y. Hu (Changchun, China), Q. Zhang (Changchun, China)
| |
Metabolite markers identify pneumonia better in serum than sputum or broncho-alveolar lavage fluid
Q. Xiao (Foshan, China), X. Zheng (Zhuhai, China), X. Liu (Foshan, China), L. Li (Shenzhen, China), F. Rong (Foshan, China)
| |
Neutrophil elastase is correlated with disease severity in a cohort from Southern Europe
A. Gramegna (Milano (MI), Italy), S. Aliberti (Milano (MI), Italy), T. Pilocane (Milano (MI), Italy), G. Sotgiu (Milano (MI), Italy), M. Ori (Milano (MI), Italy), C. Di Francesco (Milano (MI), Italy), L. Saderi (Milano (MI), Italy), A. Gelmini (Milano (MI), Italy), L. Terranova (Milano (MI), Italy), M. Oriano (Milano (MI), Italy), A. Bellofiore (Milano (MI), Italy), M. Gaffuri (Milano (MI), Italy), B. Vigone (Milano (MI), Italy), J. Chalmers (Dundee, Scotland , United Kingdom), S. Oriol (Barcelona, Spain), P. Marchisio (Milano (MI), Italy), F. Blasi (Milano (MI), Italy)
| |
Evaluating salivary IgA levels as a biomarker for susceptibility to upper respiratory tract infection in elite athletes
S. Turner (London, United Kingdom), J. Hull (London, United Kingdom), A. Jackson (London, United Kingdom), C. Ranson (London, United Kingdom), P. Kelleher (London, United Kingdom), M. Loosemore (London, United Kingdom), A. Shah (London, United Kingdom)
| |
The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum
D. McCafferty (Belfast (Belfast), United Kingdom), W. Carson-Mcneill (Coleraine, United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom)
| |
Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum
D. McCafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), B. Walker (Belfast (Belfast), United Kingdom)
| |
Diagnostic performance of multiplex bacterial PCR in BAL for bacterial pneumonia varies across molecular assays
A. Darie (Basel, Switzerland), D. Schumann (Basel, Switzerland), A. Egli (Basel, Switzerland), N. Khanna (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Evaluation of Immature Platelet Fraction (IPF) in respiratory tract infections.
V. Georgakopoulou (Athens, Greece), K. Mantzouranis (Athens, Greece), D. Mermigkis (Athens, Greece), D. Melemeni (Athens, Greece), G. Petsinis (Athens, Greece), E. Karakou (Athens, Greece), A. Lekkakou (Athens, Greece), N. Trakas (Athens, Greece), R. Chatzikyriakou (Athens, Greece), X. Tsiafaki (Athens, Greece)
| |
Vaccine-induced immunity in elite athletes undergoing respiratory assessment
S. Turner (London, United Kingdom), J. Hull (London, United Kingdom), A. Jackson (London, United Kingdom), C. Ranson (London, United Kingdom), P. Kelleher (London, United Kingdom), M. Loosemore (London, United Kingdom), A. Shah (London, United Kingdom)
| |
Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets
S. Horie (Galway, Ireland), J. Brady (Galway, Ireland), B. Mc'Nicholas (Galway, Ireland), D. O'Toole (Galway, Ireland), M. Griffin (Galway, Ireland), J. Laffey (Galway, Ireland)
| |
Bronchoalveolar lavage amylase levels can be a biomarker of aspiration pneumonia.
T. Suzuki (Aiduwakamatsu, Japan), M. Saitou (Aiduwakamatsu, Japan), Y. Utano (Aiduwakamatsu, Japan), K. Utano (Aiduwakamatsu, Japan), K. Niitsuma (Aiduwakamatsu, Japan)
| |
Significant Discrimination of unknown bacterial Infections by Analysis of VOCs in exhaled Air or Headspace from Infected Regions
G. Becher (Bernau, Germany), R. Purkhart (Chemnitz, Germany), R. Gerber (Geyer, Germany), T. Junghans (Aue, Germany), R. Graupner (Aue, Germany)
| |